Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia

Haematologica. 2024 Dec 1;109(12):4131-4136. doi: 10.3324/haematol.2024.285707.
No abstract available

Grants and funding

Funding: This work has been funded by a KIKA (329) program grant (to OH).